Please login to the form below
treatment access
This page shows the latest treatment access news and features for those working in and with pharma, biotech and healthcare.
Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on kidney cancer drug
EUSA’s Fotivda approved for NHS use in Scotland. Specialist pharma company EUSA Pharma has welcomed the Scottish Medicines Consortium approval of its renal cell carcinoma treatment Fotivda (tivozanib). ... year to access this treatment through the NHS
Latest news
-
News: Charity criticises NHS England and Vertex over Orkambi access, Sema scores again, NodThera launched
Budget holder NHS England and Vertex are currently locked in a dispute about price and market access for Orkambi, a combination drug treatment which can offer major benefits for some CF ... However in its correspondence It added that “despite
-
Daily Brief: NICE says no to Zytiga, Genentech and UK biotech sign microbiome deal
to access the treatment until their disease has progressed. ... only licensed treatment for mHSPC that can delay chemotherapy and disease progression, prolong overall survival and maintain patients’quality of life.
-
Improving childhood cancer survival rates in developing countries
in the capital) we are now promoting the development of shared care centres to give more families closer access to better treatment. ... In each, we have provided training, facility improvements, advice on treatment and holistic care.
-
Daily Brief: GDPR and NHS Opt Out Day, BioMarin's new rare disease approval and more
all patients who are eligible to benefit from this treatment are able to access it once a final recommendation is issued.”. ... NICE looks set to recommend another AML treatment, Novartis’Rydapt (midostaurin), which is for newly diagnosed acute
-
NHS England’s Simon Stevens - no Trump drug price rhetoric here
NHS England has taken on responsibility for many aspects of price setting and market access for England’s NHS in the last few years, especially for the specialised and high-cost ... In a moment of typical candour, Stevens referenced an ongoing
More from news
Approximately 1 fully matching, plus 196 partially matching documents found.
Latest Intelligence
-
Patient outcomes in practice: delivering value that transforms lives
It means we have to think big in designing programmes. We must understand how we can affect the system and improve decision-making, information, access, monitoring and treatment transitions. ... making, information, access, monitoring and treatment
-
Working with our healthcare system more closely is vital
Take a recent local NHS partnership aimed at addressing specific access and capacity issues in Southampton. ... to essential treatment, expanding and improving care for people living with a leading cause of vision loss – age-related macular
-
Simplifying HCP access to digital information
Simplifying HCP access to digital information. New industry-standards group launched. The life science industry’s commercial model has transformed significantly over the past decade. ... This new standard will improve how life science companies
-
The gold standard of scientific evidence
By randomising access to the treatment, researchers would be able to measure efficacy using robust statistical methods. ... Even social media data can be used to measure real-world treatment safety and effectiveness.
-
The real-world data conundrum
treatment options, access for populations in developing countries and an up-to-date evidence-base is ever increasing. ... when healthcare professionals will be able to provide the right treatment, for the right person, at the right dose, at the right time
More from intelligence
Approximately 1 fully matching, plus 38 partially matching documents found.
Latest appointments
-
UN names special envoy for HIV/ AIDS in Africa
Ugandan national Wandira-Kazibwe replaces Asha-Rose Migiro as the UN's lead advocate to end HIV-related stigma, improve access to treatment and improve national public health systems.
-
Basilea's Hans Christian Rohde takes up commercial role at uniQure
access to this crucial treatment to as many patients as possible. “
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
SWITCHED ONcology Patient Experience Focus Group Full Discussion
In the patient experience focus group, the discussion focused on the patient journey from pre-diagnosis right through to treatment and support. ... around treatment, access to information for both patients and hcps, patient support wellbeing and the role
-
How e-detailing can increase access to HCPs
How e-detailing can increase access to HCPs. The benefits of digital detailing don’ t stop at the cost savings or the rich streams of customer data that it produces. ... Many recognize that detailing remains a great way to get access to treatment
-
Webinar: Understanding the patient journey in China
As the affluent middle-class continues to grow and healthcare reforms look set to affect the way that patients access treatment, the Chinese healthcare market is experiencing a period of great
-
Webinar: Understanding the Patient Journey in China 2015
As the affluent middle-class continues to grow and healthcare reforms look set to affect the way that patients access treatment, the Chinese healthcare market is experiencing a period of great
-
TVF Communications shortlisted for the second year in a row for Writing Excellence award at Communique 2017
The learner is guided through a series of phases from life before the illness all the way through to treatment options, focusing on the difficulties encountered by the patient at each ... A primary aim was to overcome the challenges associated with lack
More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.
Featured jobs
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Business Unit Head, Medical Communications, London
-
Excellent package
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Senior Project Manager - Medical Writing
-
Great salary and bebefits
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
Competitive salary
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
-
Account Manager
-
£40, 000 - £45, 000 benefits
Subscribe to our email news alerts
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- NHS England says yes to Roche's Hemlibra
- Moving annual total (MAT)
- Vertex to Theresa May: Orkambi verdict ‘threatens bio investment’
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Communiqué Awards 2018: Winners in pictures - Communiqué Awards 2016
- May’s Brexit plan cautiously welcomed by biopharma sector
- Daily Brief: Novartis exits anti-infectives drive, Hancock takes over from Hunt and Trump attacks 'soft Brexit' plan
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Fishawack acquires brand communications agency Healthcircle
- Roche keeps Venclexta train rolling with new leukaemia filing
- Pfizer builds gap between pharma and consumer health units
PMHub
Swordfish Advertising
At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...
Latest intelligence
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
- The rise of vertical integration in the US payer landscape
- Is it a solution to addressing the challenges of the value-based marketplace?...
- Creativity has lost its worth
- Creativity has lost its worth, and sadly it is undermining effectiveness...
Quick links
Infographics
